期刊
EXPERT OPINION ON BIOLOGICAL THERAPY
卷 8, 期 9, 页码 1435-1447出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/14712598.8.9.1435
关键词
immune therapy; immunomodulatory effects; interferon beta; multiple sclerosis
Background: Recombinant forms of IFN-beta were the first therapeutic intervention found to be effective at interfering with the course of multiple sclerosis (MS), a chronic and debilitating disease affecting the CNS in young adults. Objective/methods: To examine the application of IFN-beta to MS treatment by a review of relevant literature. Results: The different IFN-beta products available are similar in their clinical effects. However, the response to IFN-beta therapy is only partial and the most efficient individual-specific dose, route and frequency of administration are not elucidated fully. The mechanism of action of IFN-beta in MS is also not understood fully but its immunomodulatory effects are probably more important than its anti-proliferative and antiviral activities. Conclusions: Although new therapeutic approaches are being sought to better treat MS, IFN-beta remains one of the most recognized and approved worldwide therapeutic options for this disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据